All practice questions

8270 questions

All types8,270 Multiple choice4,249 Multiple select325 Numeric160 Matching1,849 Ordering1,687

Correlate the following pediatric patient scenarios with the most appropriate targeted preventive care or immunization intervention.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Match the complement deficiency to the MenB vaccine, the older housing exposure to lead screening, the sickle cell disease to the PPSV23 vaccination, and the endemic region emigration to tuberculosis screening.

High-risk pediatric patients require precise modifications to standard preventive care. Asplenia (seen in sickle cell disease) necessitates PPSV23 to protect against encapsulated bacteria. Complement deficiencies require MenB to prevent severe meningococcal disease. Specific environmental and geographic exposures mandate targeted screening for lead toxicity and tuberculosis, respectively.

Step-by-Step Solution

Identify the primary underlying risk factor or exposure in each patient's clinical history.

Recognized complement deficiency, lead paint exposure risk, functional asplenia, and high-risk geographic origin.

Targeted preventive care relies on identifying specific risk factors that deviate from the standard, low-risk pediatric population.

Determine the indicated supplemental vaccine or screening test based on the identified risk.

Assigned MenB, lead testing, PPSV23, and TB screening to their respective clinical scenarios.

To correctly apply the guidelines from the Centers for Disease Control and Prevention and the American Academy of Pediatrics for high-risk patients.

Key Concept

Targeted preventive care and immunization schedules for high-risk pediatric populations.

Question 2462Question →

Match each clinical vignette describing an adverse reaction to a packed red blood cell (pRBC) transfusion with the most appropriate next step in management.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Acute hemolytic reaction matches with aggressive IV hydration; Febrile non-hemolytic reaction matches with administering an antipyretic; TRALI matches with supportive respiratory care; Allergic reaction matches with pausing, giving antihistamines, and resuming; and TACO matches with administering intravenous furosemide.

Each transfusion reaction has a distinct pathophysiologic mechanism that dictates its classic clinical presentation and subsequent management. Immediate life-threatening events like ABO incompatibility (Acute Hemolytic) require fluids to save the kidneys. Inflammatory but benign events (Febrile Non-Hemolytic) require simple antipyretics. Immune-mediated lung injury (TRALI) requires strict supportive respiratory care, while hydrostatic lung injury (TACO) requires aggressive diuresis. Finally, mild IgE-mediated reactions (Allergic) uniquely allow for pausing, treating the symptoms, and finishing the transfusion.

Step-by-Step Solution

Identify the cause of flank pain and dark urine shortly after starting a transfusion.

Matches aggressive IV hydration.

Diagnosis is an acute hemolytic reaction; fluids are essential to prevent pigment nephropathy and renal failure.

Evaluate isolated fever and chills without hemodynamic instability.

Matches antipyretic administration.

Diagnosis is a febrile non-hemolytic reaction, requiring only symptom control after ruling out hemolysis.

Distinguish the cause of respiratory distress with pulmonary infiltrates but normal blood pressure.

Matches supportive respiratory care.

Diagnosis is TRALI; immune-mediated capillary permeability requires respiratory support, not diuresis.

Identify the significance of isolated urticaria and pruritus without systemic signs.

Matches administering antihistamines and resuming.

Diagnosis is a mild allergic reaction; the blood product can safely be utilized after symptom resolution.

Evaluate respiratory distress accompanied by hypertension and basilar crackles in an elderly patient.

Matches intravenous furosemide.

Diagnosis is TACO; the acute volume overload must be reversed with rapid diuresis.

Key Concept

Management and identification of acute blood transfusion reactions

Question 2463Question →

A 26-year-old woman presents to the clinic for sexually transmitted infection screening. She reports having condomless sexual intercourse with a new male partner three weeks ago. She recently learned that this partner is living with HIV and is not taking any medications. She currently feels well and has no symptoms of acute illness. Vital signs and physical examination are unremarkable. The physician decides to evaluate her for HIV. Assuming her initial screening test is reactive, but her subsequent confirmatory antibody test is indeterminate, arrange the following diagnostic and management steps in the correct chronological sequence according to the standard Centers for Disease Control and Prevention (CDC) HIV algorithm.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with the HIV-1/2 antigen/antibody combination immunoassay, followed by the HIV-1/HIV-2 antibody differentiation immunoassay. Due to the indeterminate result, an HIV-1 nucleic acid test (NAT) is performed next. Finally, antiretroviral therapy (ART) is initiated and baseline labs are drawn.

The correct sequence precisely follows the CDC diagnostic algorithm for HIV. The first step is the highly sensitive fourth-generation antigen/antibody combination test. If reactive, the second step is the differentiation assay to determine if the patient has HIV-1 or HIV-2 antibodies. Because this patient is in the acute phase of infection (only 3 weeks post-exposure), she has p24 antigenemia but has not yet developed a mature antibody response, resulting in a reactive step 1 but an indeterminate step 2. This specific discrepancy mandates step 3, an HIV-1 nucleic acid test (NAT), to detect viral RNA and confirm acute HIV-1 infection. Once the diagnosis is definitively confirmed by a positive NAT, step 4 is to initiate antiretroviral therapy (ART) and obtain baseline immunologic and virologic studies such as a CD4 count.

Step-by-Step Solution

Perform the HIV-1/2 antigen/antibody combination immunoassay.

The test returns a reactive result.

This fourth-generation test is the highly sensitive initial screening tool mandated by the CDC algorithm, detecting both p24 antigen and antibodies.

Perform the HIV-1/HIV-2 antibody differentiation immunoassay.

The test returns an indeterminate result.

All reactive initial screens must be followed by this test to confirm infection and differentiate the viral type. The indeterminate result occurs because the patient is in the acute window phase (p24 antigen is present, but mature antibodies have not yet formed).

Perform an HIV-1 nucleic acid test (NAT).

The NAT returns a positive result for HIV-1 RNA.

NAT is required to resolve the discrepancy between the reactive combination test and the indeterminate differentiation test, confirming the diagnosis of acute HIV-1 infection.

Initiate antiretroviral therapy (ART) and obtain a baseline CD4 cell count.

The patient is started on a modern ART regimen.

Once the diagnosis is definitively confirmed via NAT, prompt initiation of ART is standard of care to suppress viral replication, preserve immune function, and prevent transmission.

Key Concept

Standard CDC HIV Diagnostic Algorithm and Identification of Acute HIV Infection

Question 2464Question →

Paramedics bring a lethargic $68$ -year-old male to the emergency department after his family found him confused and severely weak at home. The patient has a medical history of hypertension, hyperlipidemia, and type 2 diabetes mellitus. Vital signs upon arrival reveal a temperature of $34.8^\circ$ C ( $94.6^\circ$ F), blood pressure of $80/50$ mmHg, heart rate of $46$ /min, and respiratory rate of $8$ /min. On physical examination, the patient is somnolent but arousable to painful stimuli. His skin is cool, dry, and pale. There is non-pitting edema of the bilateral lower extremities, and deep tendon reflexes exhibit delayed relaxation phases. Lungs are clear to auscultation bilaterally, and cardiac examination reveals profound bradycardia with a regular rhythm. Initial laboratory studies show the following:

Serum sodium: $128$ mEq/L
Serum potassium: $4.0$ mEq/L
Serum chloride: $94$ mEq/L
Serum bicarbonate: $26$ mEq/L
Blood urea nitrogen: $18$ mg/dL
Serum creatinine: $1.1$ mg/dL
Serum glucose: $58$ mg/dL

Thyroid-stimulating hormone (TSH): $1.1$ $\mu$ U/mL (normal: $0.4-4.0$ $\mu$ U/mL)
Free thyroxine (T4): $0.3$ ng/dL (normal: $0.9-1.7$ ng/dL)

Arterial blood gas on room air:
pH: $7.22$
PaCO2: $65$ mm Hg
PaO2: $60$ mm Hg

Which of the following is the most appropriate initial step in the management of this patient?

Administer intravenous hydrocortisone followed by intravenous levothyroxine

Administer intravenous levothyroxine and initiate passive rewarming

Initiate noninvasive positive pressure ventilation and administer nebulized ipratropium-albuterol

Obtain blood cultures and administer empirical intravenous vancomycin and cefepime

Administer a continuous infusion of sodium bicarbonate

Show answer & explanation

Answer: Administer intravenous hydrocortisone followed by intravenous levothyroxine

Answer

The most appropriate initial step is to administer intravenous hydrocortisone followed by intravenous levothyroxine.

The patient presents with classic signs of myxedema coma (hypothermia, bradycardia, altered mental status, and delayed reflexes). The laboratory finding of a very low free T4 combined with an inappropriately normal TSH points to central (secondary) hypothyroidism. In such cases, there is a high likelihood of concurrent panhypopituitarism, including central adrenal insufficiency (further supported by the patient's hypoglycemia). The standard of care mandates that intravenous glucocorticoids (e.g., hydrocortisone) be given prior to or simultaneously with intravenous levothyroxine. Administering thyroid hormone alone acutely increases the basal metabolic rate and accelerates the hepatic clearance of cortisol, which can precipitate a fatal Addisonian crisis in a cortisol-deficient patient.

Step-by-Step Solution

Analyze the clinical presentation and vital signs.

The patient exhibits severe hypothermia, bradycardia, hypoventilation, hypotension, and delayed deep tendon reflexes.

These findings are hallmark signs of a profound hypometabolic state, specifically myxedema coma.

Interpret the endocrine laboratory results.

The free T4 is markedly low (

0.3

ng/dL) while the TSH is inappropriately normal (

1.1

\mu

U/mL).

This discrepancy indicates secondary (central) hypothyroidism rather than primary hypothyroidism. The accompanying hypoglycemia further suggests panhypopituitarism with central adrenal insufficiency.

Determine the correct pharmacological sequence for management.

Intravenous glucocorticoids (hydrocortisone) must be administered prior to intravenous thyroid hormone replacement.

Levothyroxine rapidly increases the basal metabolic rate and hepatic clearance of cortisol. In a patient with unrecognized adrenal insufficiency, this will precipitate a fatal acute adrenal crisis.

Key Concept

In myxedema coma, especially with laboratory evidence pointing toward central hypothyroidism (low free T4, inappropriately normal TSH), empiric intravenous glucocorticoids must be administered before levothyroxine to prevent precipitating an acute adrenal crisis.

Estimated Time:1m 30s

Question 2465Question →

A 38-week gestation male neonate is born via spontaneous vaginal delivery. Immediately after birth, he develops severe respiratory distress, cyanosis, and grunting. Physical examination reveals a scaphoid abdomen, absent breath sounds over the left hemithorax, and heart sounds displaced to the right. The medical team highly suspects a congenital diaphragmatic hernia. Arrange the following management steps in the most appropriate chronological sequence for this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is endotracheal intubation, followed by orogastric tube placement, then chest radiography, and finally surgical repair.

The standard sequence for managing a newborn with a suspected congenital diaphragmatic hernia focuses on immediate airway control without introducing air into the GI tract (endotracheal intubation), followed by GI decompression (orogastric tube), diagnostic confirmation (radiograph), and delayed definitive treatment (surgery) once pulmonary status is stable.

Step-by-Step Solution

Secure the airway

Endotracheal intubation is performed

Bag-mask ventilation must be avoided to prevent gastrointestinal distension and worsening respiratory compromise.

Decompress the gastrointestinal tract

Orogastric tube is placed

Decompressing the herniated bowel relieves pressure on the already hypoplastic lungs, improving ventilation.

Confirm the diagnosis

Chest radiography is obtained

A chest X-ray confirms the presence of bowel loops in the thorax after the patient is hemodynamically and chronotropically stabilized.

Perform definitive treatment

Surgical repair is scheduled

Surgery is the definitive treatment but must be delayed until pulmonary hypertension and cardiopulmonary status are optimized.

Key Concept

Initial management sequence for Congenital Diaphragmatic Hernia (CDH)

Question 2466Question →

Match each patient's clinical and microbiological presentation with the most appropriate targeted antimicrobial therapy.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Listeria monocytogenes pairs with ampicillin; ESBL-producing E. coli pairs with meropenem; invasive aspergillosis pairs with voriconazole; and MRSA pairs with vancomycin.

Each pathogen has a distinct, well-established first-line treatment. Ampicillin is uniquely active against Listeria. Carbapenems (meropenem) are stable against extended-spectrum beta-lactamases produced by resistant Gram-negative rods. Voriconazole is the antifungal of choice for invasive Aspergillus. Vancomycin provides reliable coverage for oxacillin-resistant staphylococci (MRSA).

Step-by-Step Solution

Identify the underlying pathogen described in each clinical vignette using key microbiological and serological terms.

Pathogens identified are Listeria monocytogenes, ESBL E. coli, Aspergillus species, and MRSA.

Accurate pathogen identification is required to select narrow, targeted antimicrobial therapy.

Determine the first-line targeted therapy for each identified organism.

Ampicillin for Listeria, meropenem for ESBL, voriconazole for Aspergillus, and vancomycin for MRSA.

Applying standard pharmacotherapy guidelines ensures effective treatment while adhering to antimicrobial stewardship principles.

Key Concept

Targeted Antimicrobial Therapy for Classic Pathogens

Estimated Time:1m 0s

Question 2467Question →

A 28-year-old woman, gravida 2 para 1, presents to the labor and delivery unit in active labor. Her prenatal laboratory screening is positive for Hepatitis B surface antigen (HBsAg). She delivers a healthy, full-term male newborn. The pediatric team formulates a comprehensive management pathway to prevent vertical Hepatitis B transmission, confirm the infant's immunity, and manage potential vaccine non-response. Arrange the following steps in the standard protocol for this infant in the correct chronological order, representing the sequence of interventions from birth through the management of an inadequate initial immune response (anti-HBs < 10 mIU/mL).

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: 1) Administer HepB vaccine and HBIG at birth, 2) Complete the final dose of the primary vaccine series at 6 months, 3) Perform initial post-vaccination serologic testing (PVST) at 9-12 months, 4) Administer a revaccination dose for the non-responder status, and 5) Repeat PVST 1-2 months after revaccination.

The standard protocol for infants born to HBsAg-positive mothers requires strict temporal adherence to ensure protection and accurately confirm immunity. The correct sequence begins with immediate prophylaxis at birth (vaccine + HBIG), followed by completion of the primary series by 6 months of age. Crucially, initial serologic testing (PVST) is delayed until 9-12 months to prevent the detection of waning passive HBIG antibodies. Infants who are non-responders (anti-HBs < 10 mIU/mL) then require further revaccination, which is followed by subsequent re-testing 1-2 months later to confirm seroconversion.

Step-by-Step Solution

Identify the immediate neonatal intervention for an infant born to an HBsAg-positive mother.

Hepatitis B vaccine and HBIG are administered within 12 hours of birth.

Immediate post-exposure prophylaxis drastically reduces the risk of vertical transmission.

Recognize the completion timeline for the primary Hepatitis B vaccine series.

The final dose of the primary series is administered at 6 months of age.

Standard pediatric immunization schedules conclude the primary HepB series at this age.

Determine the correct timing for post-vaccination serologic testing (PVST).

PVST is performed at 9-12 months of age.

Testing must be delayed beyond 9 months to avoid detecting passive antibodies from the HBIG administered at birth, which could mask an actual non-responder status.

Identify the next management step for an infant who shows an inadequate immune response (anti-HBs < 10 mIU/mL) on the initial PVST.

A revaccination dose of the Hepatitis B vaccine is administered.

Non-responders require additional antigenic stimulation (either a single dose or a full repeat 3-dose series) to mount a protective immune response.

Conclude with the timing of the follow-up testing after revaccination.

Repeat serologic testing for anti-HBs is performed 1-2 months later.

This window allows sufficient time for the immune system to generate measurable antibodies in response to the revaccination dose.

Key Concept

Perinatal Hepatitis B Prevention and Non-Responder Management

Question 2468Question →

An oncology team is evaluating a 47-year-old male inpatient who has had persistent fever despite ongoing antimicrobial therapy. He has been hospitalized for the past $16$ days receiving induction chemotherapy for acute myeloid leukemia. Six days prior to the current evaluation, his absolute neutrophil count dropped to $90/\text{mm}^3$ , coinciding with a new-onset fever of $39.2^\circ\text{C}$ ( $102.6^\circ\text{F}$ ). At that time, comprehensive pan-culturing was performed, and empiric intravenous piperacillin-tazobactam was initiated.

Currently, the patient's temperature is $38.9^\circ\text{C}$ ( $102.0^\circ\text{F}$ ), blood pressure is $122/78 \text{ mmHg}$ , and pulse is $95/\text{min}$ . He reports feeling exhausted but has no focal symptoms such as cough, dyspnea, sinus pain, or dysuria. Physical examination reveals a clean, non-tender central venous catheter insertion site. Cardiopulmonary and abdominal examinations are unremarkable. The absolute neutrophil count remains profoundly low at $40/\text{mm}^3$ . All previous blood and urine cultures have remained sterile after six days of incubation. High-resolution computed tomography of the chest demonstrates no pulmonary nodules or infiltrates.

Which of the following is the most appropriate next step in pharmacotherapy?

Add intravenous caspofungin

Add intravenous vancomycin

Switch piperacillin-tazobactam to meropenem

Discontinue piperacillin-tazobactam and start intravenous liposomal amphotericin B

Continue the current regimen and observe closely

Show answer & explanation

Answer: Add intravenous caspofungin

Answer

The most appropriate next step is to add an empiric antifungal agent, such as intravenous caspofungin.

Adding intravenous caspofungin is the correct next step. The patient has persistent neutropenic fever, defined as a fever lasting longer than 4 to 7 days despite receiving appropriate initial empiric broad-spectrum antibacterial therapy (in this case, piperacillin-tazobactam). In high-risk patients (such as those with profound neutropenia from induction chemotherapy), persistent fever often indicates an occult invasive fungal infection, most frequently involving Candida or Aspergillus species. Standard of care requires the addition of empiric antifungal therapy with an echinocandin (like caspofungin), a mold-active azole, or liposomal amphotericin B while continuing the antibacterial regimen until the neutrophil count recovers.

Step-by-Step Solution

Identify the patient's primary clinical syndrome.

The patient has high-risk, prolonged neutropenic fever (ANC

< 500/\text{mm}^3

) that has persisted for 6 days despite appropriate initial empiric antibacterial therapy.

Recognizing the timeline and the unresponsiveness to piperacillin-tazobactam is critical for determining the next phase of the management algorithm.

Assess the risk of secondary or occult infections.

Patients with profound and prolonged neutropenia are at an exceptionally high risk for invasive fungal infections, most commonly caused by Candida and Aspergillus species.

Fungal pathogens are a common cause of culture-negative persistent fever in hematologic malignancy patients undergoing induction chemotherapy.

Apply the standard treatment protocol for persistent neutropenic fever.

Guidelines dictate that if a high-risk neutropenic patient remains febrile after 4 to 7 days of broad-spectrum antibacterial therapy and has no identified source, an empiric antifungal agent must be added.

Early initiation of antifungal therapy reduces mortality from occult invasive fungal infections in this vulnerable population.

Select the appropriate pharmacotherapy to add.

Adding intravenous caspofungin (an echinocandin) provides excellent empiric coverage for the suspected fungal organisms.

Echinocandins, liposomal amphotericin B, or mold-active azoles are the drugs of choice in this scenario.

Key Concept

In high-risk patients with neutropenic fever that persists for 4 to 7 days despite appropriate broad-spectrum antibacterial therapy, empiric antifungal coverage (e.g., caspofungin) should be added to prevent severe morbidity and mortality from invasive fungal infections.

Estimated Time:1m 30s

Question 2469Question →

Match each patient's clinical presentation and peripheral blood smear findings to the most likely underlying pathophysiologic mechanism.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The correct matches align classic hematologic presentations with their distinct pathophysiologies: TTP is due to ADAMTS13 deficiency, ITP is due to anti-platelet antibodies, Warm AIHA is due to anti-RBC antibodies, and G6PD deficiency limits protection against oxidative stress.

Each patient's clinical scenario and lab findings perfectly align with a specific hematologic mechanism. The TTP case matches ADAMTS13 deficiency; the ITP case matches anti-platelet antibodies; the AIHA case matches anti-RBC antibodies; and the drug-induced bite cell hemolysis matches G6PD deficiency.

Step-by-Step Solution

Analyze the first presentation: fever, confusion, microangiopathic hemolytic anemia (schistocytes), and thrombocytopenia with normal coagulation studies.

Identifies Thrombotic Thrombocytopenic Purpura (TTP).

TTP classically presents with this pentad (or partial pentad) and is driven by ADAMTS13 deficiency.

Analyze the second presentation: isolated thrombocytopenia with large platelets and normal coagulation studies in an otherwise healthy young woman.

Identifies Immune Thrombocytopenia (ITP).

ITP is an autoimmune condition caused by anti-GpIIb/IIIa IgG antibodies.

Analyze the third presentation: hemolytic anemia with spherocytes and a positive direct antiglobulin test (DAT) in a patient with CLL.

Identifies Warm Autoimmune Hemolytic Anemia (AIHA).

Warm AIHA is mediated by IgG antibodies against RBC antigens and is frequently associated with CLL.

Analyze the fourth presentation: acute hemolytic anemia with bite cells following exposure to an oxidative stressor (sulfamethoxazole-trimethoprim).

Identifies Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency.

G6PD deficiency impairs the RBC's ability to produce NADPH, leading to oxidative damage when exposed to sulfa drugs.

Key Concept

The diagnosis of hematologic disorders requires integrating clinical findings, specific peripheral blood smear abnormalities, and an understanding of the underlying autoimmune or enzymatic pathophysiology.

Estimated Time:2m 0s

Question 2470Question →

A 4-day-old male neonate, born at 39 weeks gestation, is currently in the neonatal intensive care unit. He was admitted 48 hours ago for temperature instability, tachypnea, and poor feeding. A full sepsis workup was performed at admission, and empiric intravenous ampicillin and gentamicin were initiated. The infant is now clinically stable, feeding well, and afebrile. Today, the admission blood culture is finalized and demonstrates heavy growth of Streptococcus agalactiae (Group B Streptococcus) that is sensitive to penicillin, ampicillin, cefotaxime, and vancomycin. The cerebrospinal fluid culture remains sterile. During morning rounds, the nurse notes a new rash on the infant's chest and back consisting of scattered 2-mm to 3-mm erythematous macules, some with central pale-yellow pustules. The infant appears completely unbothered by the rash. A Wright-Giemsa stain of the pustular contents shows numerous eosinophils and no bacteria. Which of the following is the most appropriate next step in the management of this patient?

Discontinue gentamicin and transition to intravenous penicillin G monotherapy

Continue intravenous ampicillin and gentamicin for a complete 10-day course

Change the antibiotic regimen to intravenous vancomycin and cefotaxime

Add intravenous acyclovir and obtain viral surface swabs

Discontinue all antibiotics and observe for 24 hours prior to discharge

Show answer & explanation

Answer: Discontinue gentamicin and transition to intravenous penicillin G monotherapy

Answer

Discontinue gentamicin and transition to intravenous penicillin G monotherapy

The correct next step is to discontinue gentamicin and transition to intravenous penicillin G monotherapy. The neonate has two distinct clinical issues: confirmed Group B Streptococcus (GBS) bacteremia and a new-onset rash. For the GBS bacteremia, the patient is clinically stable and sensitivities are known. Antibiotic stewardship mandates de-escalation from empiric broad-spectrum coverage (ampicillin and gentamicin) to targeted narrow-spectrum therapy (penicillin G) to minimize toxicity and resistance. The new rash, characterized by erythematous macules with central pale-yellow pustules containing eosinophils, is a classic presentation of Erythema Toxicum Neonatorum (ETN). ETN is a benign, self-limiting condition that typically appears in the first week of life and requires no pharmacologic intervention.

Step-by-Step Solution

Evaluate the patient's current clinical status and blood culture results.

The patient has confirmed Group B Streptococcus (GBS) bacteremia with known sensitivities and is clinically improving.

Determines the primary diagnosis and need for targeted antibiotic therapy.

Apply principles of antibiotic stewardship to the current regimen.

The empiric regimen of ampicillin and gentamicin should be de-escalated to penicillin G monotherapy.

Reduces the risk of antibiotic resistance and potential toxicity from broad-spectrum agents.

Analyze the new-onset pustular rash using clinical and microscopic findings.

The rash is identified as Erythema Toxicum Neonatorum (ETN) due to its clinical appearance and eosinophil predominance on the smear.

Distinguishes a benign, self-limiting condition from a true secondary infection.

Synthesize the findings to select the next best step.

Transition to penicillin G for the GBS bacteremia and provide reassurance without additional treatment for the ETN.

Ensures appropriate targeted treatment while avoiding unnecessary interventions.

Key Concept

Neonatal Early-Onset Sepsis Management and Benign Neonatal Rashes

Estimated Time:1m 30s

Question 2471Question →

A 28-year-old male graduate student presents to the university health center reporting a 3-day history of profound fatigue, a severe sore throat, and a widespread rash. He notes that 14 days ago, he engaged in unprotected receptive anal intercourse with a new male partner whose infectious status is unknown. His temperature is $38.4^\circ\text{C}$ ( $101.1^\circ\text{F}$ ). Physical examination reveals tender cervical and axillary lymphadenopathy, pharyngeal erythema without exudate, and a diffuse maculopapular rash on the trunk and extremities. The physician suspects an acute viral illness and initiates the standard diagnostic algorithm for the most likely pathogen.

Arrange the following steps in the most appropriate chronological sequence for the diagnosis and initial management of this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: 1) HIV-1/2 antigen/antibody combination immunoassay, 2) HIV-1/HIV-2 antibody differentiation immunoassay, 3) HIV-1 NAAT, 4) Obtain baseline genotypic resistance testing, and 5) Initiate empiric antiretroviral therapy.

The standard of care for suspected acute HIV follows a strict chronological pathway. Diagnosis begins with the 4th-generation Ag/Ab immunoassay. If positive, it is followed by an antibody differentiation assay. In acute infection, the differentiation assay is negative or indeterminate because antibodies have not yet formed, which mandates an HIV-1 NAAT to confirm the diagnosis. Once confirmed, blood for genotypic resistance testing must be drawn prior to starting treatment. Finally, empiric antiretroviral therapy is initiated rapidly without waiting for the resistance results to return.

Step-by-Step Solution

Recognize the clinical presentation of acute HIV infection (acute retroviral syndrome).

The patient's timeline (14 days post-high-risk exposure) and symptoms (fever, pharyngitis, lymphadenopathy, maculopapular rash) are highly suspicious for acute HIV.

Identifying acute HIV dictates the need for a specific diagnostic algorithm, as traditional antibody-only tests will be falsely negative during this window period.

Sequence the CDC diagnostic testing algorithm for HIV.

The initial step is the 4th-generation Ag/Ab immunoassay, followed by the antibody differentiation assay, and concluding with the HIV-1 NAAT.

The 4th-generation test detects the p24 antigen early. The reflex differentiation assay will be negative/indeterminate because antibodies haven't formed yet. The NAAT resolves this by directly detecting viral RNA, confirming acute infection.

Determine the optimal sequence for initiating treatment.

Genotypic resistance testing is drawn first, followed immediately by the rapid initiation of empiric antiretroviral therapy (ART).

ART suppresses viral replication, so resistance testing must be drawn beforehand to ensure accurate baseline data. However, ART initiation should not be delayed while waiting days to weeks for these results.

Key Concept

The diagnosis of acute HIV requires a sequential algorithm: a 4th-generation Ag/Ab combination immunoassay, followed by an antibody differentiation assay (often negative in early infection), and finally an HIV-1 NAAT for confirmation. Management requires drawing genotypic resistance labs prior to the rapid initiation of empiric antiretroviral therapy.

Question 2472Question →

An infectious diseases consultation is requested for a 74-year-old woman admitted with subacute bacterial endocarditis. She has a history of osteoarthritis and underwent a screening colonoscopy with polypectomy one month ago. She presented to the hospital with three weeks of low-grade fever, severe fatigue, and a new holosystolic murmur heard loudest at the cardiac apex. Transesophageal echocardiography revealed a $14\text{ mm}$ , highly mobile vegetation on the anterior mitral valve leaflet.

Four sets of blood cultures drawn upon admission are positive for *Enterococcus faecalis*. The microbiology laboratory provides the following antimicrobial susceptibility report:

Antimicrobial	Susceptibility Result
Ampicillin	Susceptible
Ceftriaxone	Resistant
Gentamicin (high-level screen)	Resistant
Linezolid	Susceptible
Vancomycin	Susceptible

Based on the susceptibility profile provided, which of the following is the most appropriate targeted pharmacotherapy to achieve bactericidal activity in this patient?

Intravenous ampicillin and intravenous ceftriaxone

Intravenous ampicillin and intravenous gentamicin

Intravenous ampicillin monotherapy

Intravenous vancomycin and intravenous piperacillin-tazobactam

Intravenous daptomycin monotherapy

Show answer & explanation

Answer: Intravenous ampicillin and intravenous ceftriaxone

Answer

Intravenous ampicillin and intravenous ceftriaxone

The correct targeted therapy is intravenous ampicillin and intravenous ceftriaxone. Enterococcal infective endocarditis requires a bactericidal regimen, which historically consisted of ampicillin plus an aminoglycoside (e.g., gentamicin) to achieve synergy. However, this patient's isolate demonstrates high-level aminoglycoside resistance (HLAR), meaning gentamicin cannot penetrate the cell wall and will not provide synergy. The standard of care for HLAR Enterococcus faecalis endocarditis is dual beta-lactam therapy with ampicillin and ceftriaxone. Even though enterococci are intrinsically resistant to cephalosporins in vitro, ceftriaxone saturates penicillin-binding proteins (PBP) 2 and 3, allowing ampicillin to more effectively bind its targets (PBP 4 and 5). This mechanism results in profound synergistic bactericidal activity, effectively curing the endocarditis while avoiding aminoglycoside-induced nephrotoxicity.

Step-by-Step Solution

Analyze the clinical presentation and primary diagnosis.

The patient has native valve infective endocarditis caused by Enterococcus faecalis.

Establishing the specific pathogen and site of infection dictates the necessity for a prolonged, bactericidal antimicrobial regimen.

Evaluate the microbiology susceptibility report.

The isolate is susceptible to ampicillin but shows high-level resistance to gentamicin (HLAR).

Enterococci are intrinsically tolerant to many antibiotics; bactericidal activity usually requires synergy between a cell-wall active agent (like ampicillin) and an aminoglycoside. HLAR eliminates the option of using gentamicin for synergy.

Determine the alternative synergistic regimen for HLAR Enterococcus faecalis.

Ampicillin combined with ceftriaxone is selected as the optimal regimen.

Despite enterococci being intrinsically resistant to cephalosporins (as shown on the report), ceftriaxone synergizes with ampicillin by saturating complementary penicillin-binding proteins (PBPs), achieving the necessary bactericidal effect without nephrotoxicity.

Key Concept

Management of Enterococcus faecalis infective endocarditis with High-Level Aminoglycoside Resistance (HLAR) using dual beta-lactam synergy (Ampicillin + Ceftriaxone).

Estimated Time:1m 30s

Question 2473Question →

A 15-month-old girl is brought to the clinic for a routine well-child visit. She has a history of idiopathic nephrotic syndrome. Three weeks ago, she experienced a relapse and was started on oral prednisone at a dose of $2.5 \text{ mg/kg/day}$ , which she continues to take. Her immunizations are up to date through 6 months of age, but she missed her 12-month visit. Her parents report she walks independently and can build a tower of 2 blocks. She says "mama," "dada," and three other specific words, and she points to objects she wants. The parents are concerned about her language development because her older sibling was speaking in two-word phrases by this age. Vital signs are within normal limits. Physical examination reveals a cushingoid appearance but is otherwise unremarkable. Which of the following is the most appropriate next step in management for this patient?

Administer Haemophilus influenzae type b, pneumococcal conjugate, and hepatitis A vaccines; reassure the parents regarding her development

Administer Haemophilus influenzae type b, pneumococcal conjugate, hepatitis A, measles-mumps-rubella, and varicella vaccines; reassure the parents regarding her development

Administer Haemophilus influenzae type b, pneumococcal conjugate, and hepatitis A vaccines; refer for a speech and language evaluation

Administer Haemophilus influenzae type b, pneumococcal conjugate, hepatitis A, measles-mumps-rubella, and varicella vaccines; refer for a speech and language evaluation

Defer all immunizations until 1 month after corticosteroid therapy is complete; reassure the parents regarding her development

Show answer & explanation

Answer: Administer Haemophilus influenzae type b, pneumococcal conjugate, and hepatitis A vaccines; reassure the parents regarding her development

Answer

Administer Haemophilus influenzae type b, pneumococcal conjugate, and hepatitis A vaccines; reassure the parents regarding her development

The correct answer accurately synthesizes immunization guidelines and developmental assessment. The patient is receiving high-dose systemic corticosteroids (defined as

\geq 2 \text{ mg/kg/day}

\geq 20 \text{ mg/day}

of prednisone for

\geq 14 \text{ days}

). In this severely immunocompromised state, live-attenuated vaccines (e.g., measles-mumps-rubella, varicella) are strictly contraindicated due to the risk of severe, uncontrolled vaccine-strain infection. However, inactivated vaccines (e.g., Haemophilus influenzae type b, pneumococcal conjugate, hepatitis A) are perfectly safe and should be administered to keep the child as protected as possible. Regarding development, her milestones (walking, 2-block tower, 3-5 words, pointing) are entirely normal for a 15-month-old. Two-word phrases are an expected milestone for a 24-month-old. Therefore, she requires only inactivated vaccines and parental reassurance.

Step-by-Step Solution

Evaluate the patient's current immunosuppression status based on her medication.

The patient is taking prednisone at

2.5 \text{ mg/kg/day}

for the past 3 weeks.

Systemic corticosteroid therapy at doses

\geq 2 \text{ mg/kg/day}

\geq 20 \text{ mg/day}

for

\geq 14 \text{ days}

causes significant immunosuppression.

Determine which vaccines are indicated and safe to administer.

Live-attenuated vaccines (MMR, varicella) are contraindicated. Inactivated vaccines (Hib, pneumococcal conjugate, hepatitis A) are safe and should be given to catch up for the missed 12-month visit.

Live vaccines pose a risk of vaccine-strain infection in severely immunocompromised hosts, while inactivated vaccines pose no such risk.

Assess the patient's developmental milestones against standard age expectations.

Walking independently, building a 2-block tower, saying 3-5 words, and pointing are all normal and expected milestones for a 15-month-old.

Two-word phrases are not typically expected until 24 months of age, so reassurance is appropriate rather than referral.

Key Concept

Immunization guidelines for patients on immunosuppressive therapy and assessment of toddler developmental milestones.

Estimated Time:1m 30s

Question 2474Question →

A $74$ -year-old woman is brought to the emergency department by her daughter due to a recent episode of vision loss in her right eye. The patient states that while eating breakfast this morning, a "dark curtain" descended over her right eye, causing complete blindness in that eye for approximately $15$ minutes before fully resolving. Over the past $3$ weeks, she has experienced a persistent right-sided headache, generalized fatigue, and pain in her jaw muscles that worsens when she chews. Her medical history is significant for hypertension and polymyalgia rheumatica. Her temperature is $37.8^\circ\text{C}$ ( $100.0^\circ\text{F}$ ), blood pressure is $135/85\text{ mmHg}$ , and pulse is $88/\text{min}$ . Physical examination shows a prominent, nodular, and tender right temporal artery with diminished pulsation. Visual acuity is currently $20/20$ in both eyes. Laboratory studies show:

Hemoglobin: $11.2\text{ g/dL}$
Leukocyte count: $9,500/\text{mm}^3$
Erythrocyte sedimentation rate: $95\text{ mm/h}$
C-reactive protein: $45\text{ mg/L}$

Which of the following is the most appropriate next step in management?

Obtain a non-contrast computed tomography of the head

Initiate high-dose oral prednisone

Administer intravenous methylprednisolone

Perform a temporal artery biopsy

Administer intravenous ceftriaxone and vancomycin

Show answer & explanation

Answer: Administer intravenous methylprednisolone

Answer

Administer intravenous methylprednisolone

This patient's presentation is classic for giant cell arteritis (GCA), characterized by a new-onset headache, jaw claudication, an abnormal temporal artery on palpation, and a markedly elevated erythrocyte sedimentation rate (ESR). Her history of polymyalgia rheumatica further increases the pretest probability of GCA. The critical feature in this vignette is the episode of transient monocular vision loss (amaurosis fugax). In GCA, visual symptoms indicate active retinal ischemia due to arteritic anterior ischemic optic neuropathy. To prevent permanent, irreversible blindness, patients with suspected GCA and visual symptoms must receive immediate pulse intravenous methylprednisolone (typically

500

1000\text{ mg}

daily for

3

days). Once therapy is initiated, a temporal artery biopsy should be scheduled to confirm the diagnosis, as biopsy results remain reliable for

1

2

weeks after starting glucocorticoids.

Step-by-Step Solution

Identify the primary clinical syndrome.

The patient has a new-onset headache, jaw claudication, temporal artery tenderness, and a highly elevated erythrocyte sedimentation rate in the setting of polymyalgia rheumatica, which is highly suggestive of giant cell arteritis (GCA).

Recognizing the classic triad of symptoms and laboratory findings establishes the working diagnosis.

Assess for severe or organ-threatening complications.

The patient experienced a transient loss of vision (amaurosis fugax) in the right eye.

Amaurosis fugax in the setting of GCA indicates active retinal ischemia and represents an impending permanent vision loss, which significantly alters the standard treatment pathway.

Determine the most appropriate initial management based on the presence of complications.

Intravenous pulse methylprednisolone must be administered immediately.

While uncomplicated GCA is treated with oral prednisone, the presence of ischemic visual symptoms mandates aggressive intravenous glucocorticoid therapy to prevent irreversible blindness. A temporal artery biopsy should be planned but must not delay treatment.

Key Concept

Management of giant cell arteritis (GCA) with visual symptoms

Estimated Time:1m 30s

Question 2475Question →

A 68-year-old woman is admitted to the hospital with profound fatigue, exertional dyspnea, and tingling in her toes. Laboratory studies reveal a hemoglobin of $5.8\text{ g/dL}$ , a mean corpuscular volume (MCV) of $122\text{ fL}$ , and a platelet count of $105,000/\mu\text{L}$ . A peripheral blood smear demonstrates macro-ovalocytes and neutrophils with six to seven nuclear lobes. The patient is diagnosed with severe cobalamin (vitamin $B_{12}$ ) deficiency secondary to pernicious anemia, and daily intramuscular cyanocobalamin therapy is initiated.

Arrange the following anticipated clinical and hematologic responses in the correct chronological order of their occurrence, from earliest to latest.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: Intracellular shift of potassium (1-2 days) → Peak elevation of reticulocyte count (5-8 days) → Clearance of hypersegmented neutrophils (10-14 days) → Normalization of hemoglobin concentration (4-8 weeks) → Complete normalization of MCV (3-4 months).

The physiological response to cobalamin replacement follows a strict timeline dictated by cellular kinetics. Marrow conversion and the resulting intracellular potassium shift occur first (1-2 days). This allows for the production and release of reticulocytes, which peak shortly after (5-8 days). As normal hematopoiesis resumes, the preexisting hypersegmented neutrophils die off according to their short lifespan (10-14 days). Hemoglobin levels gradually build up over several weeks (4-8 weeks). Finally, because the large, abnormal red blood cells produced before treatment survive for 120 days, the MCV takes the longest to normalize (3-4 months).

Step-by-Step Solution

Identify the earliest metabolic change resulting from bone marrow conversion.

Intracellular shift of potassium leading to potential hypokalemia.

Initiation of cyanocobalamin triggers immediate proliferation of hematopoietic precursors. This rapid cell division requires massive cellular uptake of potassium, occurring within the first 24-48 hours.

Identify the earliest peripheral blood evidence of new red blood cell production.

Peak elevation of the peripheral blood reticulocyte count.

As new erythrocytes are manufactured, reticulocytes enter the bloodstream. This count begins to rise by day 3 and peaks between days 5 and 8.

Determine the timeline for the disappearance of abnormal leukocyte morphology.

Clearance of hypersegmented neutrophils from the peripheral smear.

Circulating hypersegmented neutrophils must complete their natural lifespan (a few days) before they are entirely replaced by normal neutrophils, which typically takes 10 to 14 days.

Determine the timeline for the restoration of normal oxygen-carrying capacity.

Normalization of the hemoglobin concentration.

Hemoglobin rises steadily at a rate of approximately

1\text{ g/dL}

per week, requiring 4 to 8 weeks to reach the normal reference range.

Determine the timeline for the clearance of all previously formed abnormal red blood cells.

Complete normalization of the mean corpuscular volume (MCV).

Because red blood cells live for 120 days, the macrocytic cells produced prior to therapy remain in circulation for months. The MCV will not fully normalize until these older cells have all undergone senescence (up to 3-4 months).

Key Concept

Timeline of physiologic and hematologic responses to cobalamin replacement in severe megaloblastic anemia

Question 2476Question →

A female neonate, born at 40 weeks gestation following an uncomplicated pregnancy, is examined in the nursery on her second day of life due to a new-onset skin eruption. Her vital signs are within normal limits, and she is feeding vigorously without distress. Physical examination reveals scattered, splotchy erythematous macules, some of which contain central 1- to 2-mm pale yellow pustules. These lesions are prominent on her chest, back, and proximal arms, but are notably absent on her palms and soles. She exhibits normal primitive reflexes and has no apparent lymphadenopathy or hepatosplenomegaly. Which of the following is the most appropriate next step in the management of this patient's dermatologic findings?

Reassurance and routine neonatal care

Initiation of intravenous acyclovir therapy

Administration of intravenous ampicillin and gentamicin

Application of topical mupirocin to the lesions

Obtaining a viral swab of the pustules for polymerase chain reaction

Show answer & explanation

Answer: Reassurance and routine neonatal care

Answer

Reassurance and routine neonatal care

The correct management is reassurance and routine care because the clinical presentation is classic for erythema toxicum neonatorum (ETN). ETN is a benign, idiopathic, self-limited eruption that occurs in up to half of all full-term neonates, typically appearing within the first 24 to 72 hours of life. It is characterized by small, yellow-to-white papules or pustules surrounded by a wide erythematous base (often described as having a 'flea-bitten' appearance). Crucially, these lesions completely spare the palms and soles, and the infant is otherwise entirely healthy and well-appearing. Because ETN resolves spontaneously over several days to a week without sequelae, no diagnostic workup or pharmacologic treatment is indicated.

Step-by-Step Solution

Identify the key clinical features of the rash.

The rash consists of erythematous macules with central yellow pustules, primarily on the trunk and proximal extremities, sparing the palms and soles, appearing on day 2 of life.

Accurate characterization of the morphology, timing, and distribution of neonatal rashes is essential for diagnosis.

Evaluate the patient's overall clinical status.

The neonate is afebrile, feeding well, and has normal tone and reflexes, indicating a completely well-appearing child.

Systemic symptoms (e.g., fever, lethargy, poor feeding) differentiate dangerous infectious etiologies from benign physiologic rashes.

Synthesize the findings to establish a diagnosis.

The combination of the specific rash morphology, its timing, the classic sparing of the palms and soles, and the well-appearing status of the infant points definitively to erythema toxicum neonatorum (ETN).

ETN is a classic, benign, and transient condition that does not require medical intervention.

Determine the appropriate management.

Reassurance and routine care are indicated without the need for medications or further testing.

Because ETN is self-limited and non-infectious, medical interventions and invasive testing are contraindicated.

Key Concept

Erythema toxicum neonatorum is a common, benign, self-limited rash in neonates characterized by erythematous macules with central pustules that spare the palms and soles, requiring only clinical observation and parental reassurance.

Estimated Time:1m 0s

Question 2477Question →

A 55-year-old man is evaluated in the hospital prior to discharge. Three days ago, he was admitted for a diabetic foot infection characterized by a 3-cm area of erythema, induration, and warmth surrounding a shallow, non-purulent ulcer on the plantar surface of his right foot. Upon admission, he was afebrile, and his vital signs were within normal limits. He was started on empiric intravenous vancomycin and piperacillin-tazobactam. Today, the erythema has decreased to 1 cm, and the patient is ambulating without difficulty. Deep tissue cultures obtained during initial debridement on admission have grown methicillin-susceptible Staphylococcus aureus (MSSA) and Streptococcus agalactiae. Susceptibility testing shows both isolates are sensitive to cefazolin, cephalexin, and amoxicillin-clavulanate. The patient is tolerating a regular diet. Which of the following is the most appropriate antibiotic regimen for this patient upon discharge?

Oral linezolid and oral amoxicillin-clavulanate

Oral moxifloxacin

Oral cephalexin

Intravenous cefepime

Intravenous vancomycin and oral ciprofloxacin

Show answer & explanation

Answer: Oral cephalexin

Answer

Oral cephalexin

Oral cephalexin is the most appropriate next step because it provides targeted, narrow-spectrum coverage against the specific identified organisms (MSSA and Streptococcus agalactiae). The patient is clinically stable, recovering well, and tolerating a regular diet, which safely allows for the discontinuation of broad-spectrum intravenous therapy (vancomycin and piperacillin-tazobactam) in favor of a highly bioavailable, targeted oral agent.

Step-by-Step Solution

Identify the patient's clinical status and trajectory.

The patient is clinically improving, hemodynamically stable, and tolerating oral intake.

This establishes that the patient is a safe candidate for transition from intravenous to oral antibiotic therapy.

Analyze the deep tissue culture and susceptibility data.

Cultures grew methicillin-susceptible Staphylococcus aureus (MSSA) and Streptococcus agalactiae, both of which are sensitive to first-generation cephalosporins.

Definitive culture data from deep tissue is the gold standard for guiding targeted therapy in diabetic foot infections.

Apply principles of antibiotic stewardship.

Select oral cephalexin to complete the treatment course.

De-escalating from broad-spectrum empiric therapy to the narrowest-spectrum, effective oral agent minimizes adverse effects, reduces healthcare costs, and prevents the emergence of antimicrobial resistance.

Key Concept

De-escalation of empiric broad-spectrum antibiotics to targeted, narrow-spectrum oral therapy based on clinical improvement and definitive culture susceptibilities.

Question 2478Question →

Match each clinical vignette describing a patient with a hypercoagulable or thrombotic disorder to the underlying pathophysiologic mechanism responsible for their presentation.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Factor V Leiden matches to the inherited mutation resisting natural anticoagulants; Antiphospholipid syndrome matches to autoantibodies affecting phospholipid assays; Polycythemia vera matches to the acquired JAK2 mutation; Warfarin-induced skin necrosis matches to the rapid depletion of a short half-life protein.

Each clinical scenario uniquely maps to a distinct mechanism of hypercoagulability. The presentation of APC resistance is exclusive to Factor V Leiden. The inhibitor pattern on mixing study that corrects with phospholipids is the defining laboratory feature of Lupus Anticoagulant. Pancytosis with low EPO and an atypical venous thrombosis points unequivocally to the JAK2 mutation in Polycythemia Vera. Finally, skin necrosis upon warfarin initiation is the classic presentation of a rapid, drug-induced decline in Protein C.

Step-by-Step Solution

Analyze the first vignette describing activated protein C (APC) resistance.

Identify Factor V Leiden, a condition caused by a missense mutation in Factor V that prevents its normal cleavage and degradation by APC.

Connecting the diagnostic laboratory finding (APC resistance) to its fundamental genetic etiology.

Analyze the second vignette describing recurrent miscarriages and a specific coagulation mixing study profile.

Identify Lupus Anticoagulant (Antiphospholipid Syndrome), where autoantibodies prolong aPTT in vitro (inhibitor pattern) but correct with excess phospholipids.

Distinguishing between factor deficiencies and specific autoimmune inhibitors using standard mixing studies.

Analyze the third vignette detailing portal vein thrombosis, aquagenic pruritus, and pancytosis with low EPO.

Diagnose Polycythemia Vera, a myeloproliferative neoplasm caused by an acquired JAK2 tyrosine kinase mutation.

Recognizing the classic clinical presentation of PV and linking it to its molecular basis.

Analyze the fourth vignette describing necrotic skin lesions occurring shortly after starting a new oral anticoagulant.

Identify warfarin-induced skin necrosis, which occurs due to the rapid decline of Protein C before other procoagulant factors fall.

Linking the adverse drug reaction timeline to the pharmacokinetics of vitamin K-dependent factors.

Key Concept

Pathophysiology and diagnostic hallmarks of acquired and inherited hypercoagulable states (Factor V Leiden, Antiphospholipid Syndrome, Polycythemia Vera, and Protein C deficiency/Warfarin necrosis).

Estimated Time:2m 0s

Question 2479Question →

A 72-year-old man is evaluated on postoperative day 3 following an elective open inguinal hernia repair. He complains of sudden, severe pain and swelling in his right knee that woke him from sleep. His medical history is significant for chronic kidney disease with a baseline serum creatinine of 2.6 mg/dL, and hypertension. His current medications include subcutaneous enoxaparin and oral diltiazem. Temperature is 38.3°C (100.9°F), blood pressure is 142/84 mm Hg, and heart rate is 92/min. Physical examination shows a warm, markedly swollen, and erythematous right knee. Range of motion is severely limited by pain. Laboratory studies show a leukocyte count of 12,500/µL and a serum creatinine of 2.7 mg/dL. Arthrocentesis of the right knee yields 25 mL of turbid yellow fluid. Synovial fluid analysis reveals a leukocyte count of 35,000/µL (85% neutrophils). Polarized light microscopy demonstrates numerous rhomboid-shaped crystals with positive birefringence. Gram stain reveals no organisms. Which of the following is the most appropriate next step in the management of this patient?

Obtain a chest radiograph and blood cultures

Oral indomethacin

Intra-articular triamcinolone injection

Oral colchicine

Intravenous vancomycin and ceftriaxone

Show answer & explanation

Answer: Intra-articular triamcinolone injection

Answer

Intra-articular triamcinolone injection

The most appropriate next step in management is an intra-articular glucocorticoid injection. This patient is experiencing an acute flare of calcium pyrophosphate deposition (CPPD) disease (pseudogout). This diagnosis is established by the acute monoarticular presentation and the synovial fluid analysis demonstrating an inflammatory effusion with rhomboid-shaped, positively birefringent crystals. First-line therapies for an acute pseudogout flare include NSAIDs, colchicine, and glucocorticoids (systemic or intra-articular). However, this patient's advanced chronic kidney disease (serum creatinine 2.7 mg/dL) strictly contraindicates the use of NSAIDs. Colchicine is also a poor choice due to its reliance on renal clearance and an extremely dangerous drug-drug interaction with diltiazem (a moderate CYP3A4 inhibitor). Concomitant use of colchicine and a CYP3A4 inhibitor in a patient with renal failure strongly risks fatal colchicine toxicity. For acute monoarthritis in a patient with multiple systemic comorbidities and contraindications, an intra-articular glucocorticoid injection (such as triamcinolone) provides targeted, highly effective relief with negligible systemic absorption or renal risk.

Step-by-Step Solution

Diagnose the underlying acute joint pathology using synovial fluid analysis.

The presence of an inflammatory fluid (35,000 leukocytes/µL) with numerous rhomboid-shaped, positively birefringent crystals and a negative Gram stain confirms an acute flare of calcium pyrophosphate deposition (CPPD) disease (pseudogout).

Establishing the correct diagnosis prevents unnecessary empiric therapies, such as antibiotics for septic arthritis.

Evaluate standard first-line therapies for acute CPPD arthritis against the patient's comorbidities.

First-line therapies include NSAIDs, colchicine, and systemic or intra-articular glucocorticoids. The patient has stage 4 chronic kidney disease (CKD).

Renal function heavily dictates the safety profile of standard rheumatologic medications.

Eliminate contraindicated or highly risky pharmacologic options.

NSAIDs (e.g., indomethacin) are contraindicated in advanced CKD. Colchicine requires severe dose reduction in CKD and is further contraindicated here because the patient takes diltiazem, a CYP3A4 inhibitor that blocks colchicine metabolism, risking fatal toxicity.

Preventing severe iatrogenic harm, including acute-on-chronic renal failure and colchicine toxicity (neuromyopathy, myelosuppression).

Select the safest, most effective remaining intervention.

Intra-articular glucocorticoid injection (e.g., triamcinolone) is chosen.

It provides rapid, targeted anti-inflammatory effects for a single joint without significant systemic absorption, bypassing renal and metabolic contraindications.

Key Concept

For patients with an acute flare of calcium pyrophosphate deposition (CPPD) disease who have severe renal impairment or take interacting medications (e.g., CYP3A4 inhibitors), intra-articular glucocorticoids are the safest and most appropriate initial therapy.

Question 2480Question →

A 62-year-old man comes to the physician due to a 3-month history of progressively worsening fatigue, shortness of breath when climbing stairs, and a tingling sensation in both feet. He has a history of type 2 diabetes mellitus, hypertension, and osteoarthritis. His current medications include metformin, lisinopril, and acetaminophen. Vital signs are within normal limits. Physical examination demonstrates marked conjunctival pallor and decreased vibratory sensation in the lower extremities bilaterally. Lung fields are clear to auscultation. There is no jugular venous distention or lower extremity edema. Laboratory studies reveal:

Hemoglobin: 8.8 g/dL
Mean corpuscular volume (MCV): 114 fL
White blood cell count: 4,800/mm³
Platelet count: 140,000/mm³

A peripheral blood smear demonstrates macro-ovalocytes and several neutrophils with six or more nuclear lobes.

Which of the following is the most appropriate next step in the management of this patient?

Initiate intravenous furosemide therapy

Prescribe a course of oral levofloxacin

Order a serum vitamin B12 level

Measure thyroid-stimulating hormone and free T4 levels

Discontinue lisinopril and start a different antihypertensive agent

Show answer & explanation

Answer: Order a serum vitamin B12 level

Answer

The most appropriate next step is to order a serum vitamin B12 level to confirm the diagnosis before initiating supplementation.

The correct answer involves ordering a serum vitamin B12 level. The patient presents with classic clinical and laboratory signs of megaloblastic anemia, which is characterized by a significantly elevated mean corpuscular volume (MCV > 110 fL) and the pathognomonic presence of hypersegmented neutrophils on a peripheral blood smear. Furthermore, the patient exhibits neurologic symptoms, specifically peripheral neuropathy with decreased vibratory sensation, which is a hallmark of vitamin B12 (cobalamin) deficiency and reliably distinguishes it from folate deficiency. The patient is also taking metformin, a medication well-known to interfere with calcium-dependent terminal ileum absorption of the intrinsic factor-vitamin B12 complex. Before initiating targeted replacement therapy, standard medical practice dictates confirming the diagnosis by measuring serum vitamin B12 levels.

Step-by-Step Solution

Analyze the clinical presentation and laboratory results.

The patient has a macrocytic anemia (MCV = 114 fL) combined with neurologic symptoms (tingling, decreased vibratory sensation).

Identifying the type of anemia narrows down the differential diagnosis significantly.

Interpret the peripheral blood smear findings.

The presence of macro-ovalocytes and hypersegmented neutrophils (> 5 nuclear lobes) is identified.

These findings are highly specific for megaloblastic anemia, which is primarily caused by defective DNA synthesis.

Synthesize the findings with the patient's history.

Megaloblastic anemia with dorsal column neurologic signs strongly points to vitamin B12 deficiency. The patient's long-term use of metformin is a known pharmacological risk factor for this deficiency.

Connecting the pathophysiology to the patient's specific medication list establishes the most likely etiology.

Determine the most appropriate initial management step.

Ordering a serum vitamin B12 level is chosen as the next step.

Before initiating lifelong or long-term replacement therapy, the suspected deficiency must be formally confirmed via laboratory testing.

Key Concept

Recognition of megaloblastic anemia, its association with vitamin B12 deficiency (often secondary to long-term metformin use), and the appropriate initial diagnostic workup.

Alternative Method

If the initial serum vitamin B12 level returns in the low-normal or borderline range (typically 200-300 pg/mL), measuring serum methylmalonic acid (MMA) is the best alternative method to confirm tissue-level B12 deficiency, as MMA will be consistently elevated.

Estimated Time:1m 0s

PreviousPage 124 / 414Next

All practice questions

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept